The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Open accessAbstract
The INK4a-ARF locus encodes two proteins, p16(INK4a) and p19(ARF), that restrain cell growth by affecting the functions of the retinoblastoma protein and p53, respectively. Disruption of this locus by deletions or point mutations is a common event in human cancer, perhaps second only to the loss of p53. Using insect cells infected with baculovirus vectors and NIH 3T3 fibroblasts infected with ARF retrovirus, we determined that mouse p19(ARF) can interact directly with p53, as well as with the p53 regulator mdm2. ARF can bind p53-DNA complexes, and it depends upon functional p53 to transcriptionally induce mdm2 and the cyclin-dependent kinase inhibitor p21(Cip1), and to arrest cell proliferation. Binding of p19(ARF) to p53 requires the ARF N-terminal domain (amino acids 1-62) that is necessary and sufficient to induce cell cycle arrest. Overexpression of p19(ARF) in wild type or ARF-null mouse embryo fibroblasts increases the half-life of p53 from 15 to approximately 75 min, correlating with an increased p53-dependent transcriptional response and growth arrest. Surprisingly, when overexpressed at supra-physiologic levels after introduction into ARF-null NIH 3T3 cells or mouse embryo fibroblasts, the p53 protein is handicapped in inducing this checkpoint response. In this setting, reintroduction of p19(ARF) restores p53's ability to induce p21(Cip1) and mdm2, implying that, in addition to stabilizing p53, ARF modulates p53-dependent function through an additional mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under most conditions ARF functions as a tumor suppressor by binding and inhibiting Mdm2 activity [47–49].”
From Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis (2012) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Self-citationTodaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Research works printed but not linked: 10
- M Hollstein, K Rice, M S Greenblatt, T Soussi, R Fuchs, T Sorlie, E Hovig, B Smith-Sorensen, R Montesano, C C Harris Nucleic Acids Res 22, 3551–3555 (1994).
- D Duro, O Bernard, V Della Valle, R Berger, C-J Larsen Oncogene 11, 21–29 (1995).
- L Mao, A Merlo, G Bedi, G I Shapiro, C D Edwards, B J Rollins, D Sidransky Cancer Res 55, 2995–2997 (1995).
- S Stone, P Jiang, P Dayananth, S V Tavtigian, H Katcher, D Parry, G Peters, A Kamb Cancer Res 55, 2988–2994 (1995).
- 10.1128/mcb.13.7.4107-4114.1993 · DOI
- P W Hinds, C A Finlay, R S Quartin, S J Baker, E R Fearon, B Vogelstein, A J Levine Cell Growth Diff 1, 571–580 (1990).
- 10.1128/mcb.7.8.2745-2752.1987 · DOI
- 10.1126/science.256.5058.827 · DOI
- 10.1128/mcb.2.9.1044-1051.1982 · DOI
- G Shaulsky, N Goldfinger, M S Tosky, A J Levine, V Rotter Oncogene 6, 2055–2065 (1991).
Cited by
Sorted by citations
Items 801–896 of 896
CD 43 mõju uurimine rakkude kasvule
Jääger, K. (2007) · DSpace repository (University of Tartu)
Experimental brain tumors, dendritic cells and immunotherapy
Janelidze, S. (2008) · Lund University Publications (Lund University)
Keersmaecker, K. D., & Ferrando, A. A. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_26
Microarrays in Molecular Profiling of Ewing Sarcoma Family of Tumors and CDKN2A Aberrations
Savola, S. P. (2009) · Työväentutkimus Vuosikirja
Postnatal Notch1 activation induces T-cell malignancy in conditional and inducible mouse models
Liu, J., Dong, F., Fung, I., Chen, E., ALLEN, T. D., Deutsch, U., & Lobe, C. G. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2626
Spodoptera frugiperda FKBP‐46 is a consensus p53 motif binding protein
Mohareer, K., Sahdev, S., & Hasnain, S. E. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24429
Zamin, L. L. (2010) · Americanae (AECID Library)
Tumor-Specific Replicating Adenoviruses
Vecil, G. G., Fueyo-Margareto, J., & Lang, F. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-222-9_19
Heterogeneous activation of p19Arf in pulmonary artery smooth muscle cells.
Solodushko, V., Alvarez, D., Viator, R., Messerall, T., & Fouty, B. (2011) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00117.2010
Genetic Pathways in the Evolution of Gliomas
Ohgaki, H., & Kleihues, P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-843-9:207
Modification of MDMX by Ubiquitination and Sumoylation
Pan, Y. (2005) · Digital Commons - University of South Florida (University of South Florida)
Mechanisms of KRAS-Mediated Pancreatic Tumor Formation and Progression: A Dissertation
Appleman, V. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ekp2-9e89
Chemoprevention of Familial Melanoma
Hariharan, V. (2011) · Loyola eCommons (Loyola University of Chicago)
Wang, E., Marcotte, R., Papaconstantinou, H. T., & Papaconstantinou, J. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)04032-9
Ran, C. (2007) · The Knowledge Bank (The Ohio State University)
Genes and signaling pathways affecting the pathogenesis of melanoma
Varughese, B. E., & Tarapore, R. S. (2013) · Postdoc Journal · doi:10.14304/surya.jpr.v1n2.4
CARF Regulates Cellular Senescence and Apoptosis through p53-Dependent and -Independent Pathways
Wadhwa, R., Singh, R., Kaul, Z., & Kaul, S. C. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-456-2_8
Zambetti, G. P., & Ribeiro, R. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_12
Self-citationIncreased Radioresistance and Accelerated B Cell LymphomasinMicewithMdmxMutationsthatPrevent
Wang, Y. V., Leblanc, M., Wade, M. R., Jochemsen, A. G., & Wahl, G. M. (2009)
"Analiza wariantów sekwencyjnych w odcinku 3'UTR genu CDKN2A u chorych na czerniaka".
Mackiewicz, A. A. (2011)
Polycomb Group of Genes and the Epigenetics of Aging
Mishra, K., & Mishra, R. K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_8
Costa, J. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Phospho-regulation and metastatic potential of Murine Double Minute 2
Batuello, C. N. (2012) · doi:10.7912/c2/1866
den Besten, W. (2007) · UvA-DARE (University of Amsterdam)
Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)
AKT EM NEOPLASIAS BENIGNAS DE GLÂNDULA SALIVAR
Paulo, S. (2006)
Castañeda, D. B., González, P., Rocío, M., Ortega, R., Iván, H., & Torres, Z. (2007)
Vieira, I. D. L. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-06062016-104103
Etiology of Nonmelanocytic Skin Cancer
Benjamin, C. L., & Ananthaswamy, H. N. (2013) · CRC Press eBooks · doi:10.3109/9781420021097-5
Current state of the evolving MMMN cancer progression models of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.022
Gene Therapy: Technologies and Applications
Morishita, R., & Nakagami, H. (2013)
Takimoto, R., & El‐Deiry, W. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50005-9
Lees, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50007-5
Pozzi, M. (2011) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/pozzi-marco_phd2011-01-17
Gene therapy for cancer treatment
Kagawa, S., & Fujiwara, T. (2013) · doi:10.2217/ebo.12.279
Recent Advances for Targeted Therapies in Glioblastoma
Youssef, M. N., Mandel, J. J., Chowdhary, S. A., & Kesari, S. (2017) · Current cancer research · doi:10.1007/978-3-319-56820-1_4
Ribeiro, A. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-04112016-142136
Green Tea Polyphenols and Skin Protection
Gao, X., Zhang, L., Wu, Y., Li, Y., & Chen, H. (2012) · Tea in Health and Disease Prevention · doi:10.1016/b978-0-12-384937-3.00078-1
MOAP-1: A Candidate Tumor Suppressor Protein
Law, J. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3v60p
Martín‐Renedo, J. (2011) · Buleria (Universidad de León) · doi:10.18002/10612/1751
Identification and characterization of novel drugs for the treatment of pediatric gliomas
Ajeawung, N. F. (2014) · Corpus Université Laval (Université Laval)
MODULATION OF P53 SIGNALING IN an APT121 INDUCED PROSTATE CANCER MODEL
Pan, W. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wskz-eh51
Transcriptional regulation of ARF tumor suppressor
Zeng, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tvpm-m937
In Vivo Discoveries in MDM2-Mediated p53 Regulation
Tackmann, N. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7ta-7m83
p16 and ARF: Crossroads of Tumorigenesis
Yarbrough, W. G., & Xiong, Y. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00185-4
Park, J., Kim, J.-I., Lim, H.-J., Ryu, S.-K., Kwon, E., Han, K. M., Nam, K.-T., Lee, H., & Kang, B.-C. (2020) · Genes & Genomics · doi:10.1007/s13258-020-00959-z
Molecular Imaging of Gene Therapy
Paulmurugan, R., & Massoud, T. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00064-8
Etiology of Nonmelanocytic Skin Cancer
Benjamin, C. L., & Ananthaswamy, H. N. (2006) · CRC Press eBooks · doi:10.3109/9781420021097-3
Garbe, C., & Schittek, B. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_4
Scharte, J. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8911
Biologie des cancers bronchiques
Madelaine, J., & Zalcman, G. (2005) · Encyclopédie médico-chirurgicale. Pneumologie · doi:10.1016/s1155-195x(05)28766-2
Lindström, M. S., Asker, C., & Wiman, K. G. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0473
TP53-status dependent oncogenic EZH2 Activity in Pancreatic Cancer
Versemann, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9359
Pinning Control to Regulate Cellular Response in Cancer for the p53-Mdm2 Genetic Regulatory Network
Suárez, O. J., Vega, C. J., Sanchez, E. N., Chen, G., Santiago, A. E. G., Rodríguez-Jorge, O., Alanís, A. Y., & Hernandez-Vargas, E. A. (2022) · Emergence, complexity and computation · doi:10.1007/978-3-031-04379-6_6
The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation
Giansanti, C. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9741
Hu, R., Peng, G., Dai, H., Breuer, E.-K. Y., Stemke‐Hale, K., Li, K., Gonzalez-Angulo, A. M., Mills, G. B., & Lin, S. (2023) · doi:10.1158/0008-5472.c.6502727.v1
Idogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., & Tokino, T. (2023) · doi:10.1158/1078-0432.c.6516900
Idogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., & Tokino, T. (2023) · doi:10.1158/1078-0432.c.6516900.v1
Tudu, N., Sarkar, A., Mondal, S., Bandyopadhyay, B., & Panja, A. S. (2023) · Biology Bulletin · doi:10.1134/s1062359021101738
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Brizuela, L., Gyuris, J., & Mansuri, M. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_8 · Cited by 2
Molecular Mechanism of YTHDF2 Inhibiting the Occurrence and Progression of NSCLC
许, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152567
Önal, H. T., Aydemir, E., & Ayaz, F. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107450
Novel concepts in MDM2 protein regulation
Worrall, E. G. (2009) · ERA
Experimental studies on ErbB targeted therapy in malignant melanoma
Severinsson, E. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Analysis of sun-damaged skin and epidermal p53 clones.
Bäckvall, H. (2003) · Uppsala University Publications (Uppsala University)
Treré, D., Montanaro, L., Derenzini, M., Agostinelli, C., & Derenzini, E. (2026) · Oncology Reviews · doi:10.3389/or.2025.1740261
Schmitt, T. M., Furiya, K., Black, C., Vazquez, A., Sharma, J., Hailemariam, M., Paushter, D. H., Trieu, L., Lam, J. L., Lee, B., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013520
Figel, S. A., & Fenstermaker, R. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27356-8.00052-8
Cudejko, C. (2010) · theses.fr (ABES) · doi:10.70675/3be56540zf3b1z4ee1z99ffz2dbbe7a0dc17
Etude des marqueurs de progression tumorale dans les cancers HPV-induits
Brochot-Dorigny, A. (2013) · theses.fr (ABES) · doi:10.70675/d6643687z76b0z4200zbfb2zfd4986de1fbc
Investigating cancer aetiology through the analysis of somatic mutation signatures
Ardin, M. (2016) · theses.fr (ABES) · doi:10.70675/c508b0eez4695z40dez83c2z943ce312732c
Generation of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Etude des mécanismes permettant la croissance des métastases de mélanome
Stubbs, E. (2021) · theses.fr (ABES) · doi:10.70675/bfc19e04zc0b1z4149za281z741dd849ce2c
Mechanisms of precocious ageing in a human progeroid syndrome
Molina, C. F. (2021) · theses.fr (ABES) · doi:10.70675/f78c9fa2z621cz48b6zbf00z1133c36b723a
Mdm2-p53 Signaling in Tissue Homeostasis and the DNA Damage Response: A Dissertation
Gannon, H. (2012) · eScholarship@UMassChan · doi:10.13028/sfjc-xh51
Role of MDM2 In Cell Growth Regulation
Frum, R. A. (2006) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/rfjj-a657
Investigating Cancer Molecular Genetics using Genome-wide RNA Interference Screens: A Dissertation
Serra, R. W. (2013) · eScholarship@UMassChan · doi:10.13028/m2b308
Kohlhuber, F., & Eick, D. (2000) · Basic science for the cardiologist · doi:10.1007/978-0-585-38143-5_4
The Molecular Biology of Diffuse Low-Grade Gliomas
Marko, N. F., & Weil, R. J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2213-5_8
Retinoblastoma Protein in Growth Control and Differentiation
Stepanova, L., & Harper, J. W. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_6
Metadata
- Authors
- Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Howard Hughes Medical Institute and Departments of Tumor Cell Biology and Biochemistry, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105
- Corresponding author
- Sherr, Charles J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 8292-8297
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC20969
- OpenAlex
- W2141529421
- Cited by
- 899
- References
- 61
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 26 · 2015: 21 · 2014: 33 · 2013: 28 · 2012: 34
- FWCI
- 31.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- St. Jude Children's Research Hospital (CA21765)
- American Lebanese Syrian Associated Charities (CA 21765)
- National Institutes of Health (CA21765))
- National Cancer Institute (R01CA063230, CA-71907, CA-63230, CA21765, P30CA021765, P01CA071907)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- p19ARF, p53, MDM2, INK4a/ARF locus, p16INK4a, protein-protein interaction, p53 stabilization, p21 Cip1, cell cycle arrest, p53-dependent transcription, tumor suppressor, p53 DNA binding, N-terminal domain
- MeSH terms
- Animals, Humans, Neoplasm Proteins, Nuclear Proteins, Proteins, Proto-Oncogene Proteins, Retroviridae, Transfection, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, 3T3 Cells, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review